Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Acta Endocrinol (Copenh) ; 127(5): 449-53, 1992 Nov.
Article in English | MEDLINE | ID: mdl-1335201

ABSTRACT

Ketoconazole is an imidazole derivative used as an antimycotic agent with reported effects on the endocrine system, but very little is known about its possible actions on thyroid function. Our purpose was to study the influence of this substance on the basal and TSH-stimulated iodide uptake in the rat thyroid cell strain FRTL-5. Ketoconazole (1-50 mumol/l) was shown to slightly increase the basal iodide uptake but, at higher concentrations (75-100 mumol/l), it sharply decreased iodide uptake below the basal levels. When the cells were cultured under bTSH stimulation (30 UI/l), the inhibitory effect of ketoconazole was exerted at concentrations as low as 25 mumol/l. This inhibition was observed even if it was added to the culture medium immediately before the Na125I addition. Forskolin, a stimulator of adenylate cyclase activity, was unable to prevent the iodide uptake inhibition. Low doses of ketoconazole increased cAMP concentrations. In the presence of TSH this effect was more evident in an inverse dose-dependent way. Because of its dual action, it can be assumed that ketoconazole could influence the iodide uptake in the FRTL-5 cells through more than one mechanism.


Subject(s)
Iodides/pharmacokinetics , Ketoconazole/pharmacology , Thyroid Gland/metabolism , Animals , Cattle , Cell Line , Colforsin/pharmacology , Cyclic AMP/metabolism , Rats , Thyroid Gland/cytology , Thyrotropin/antagonists & inhibitors , Thyrotropin/metabolism , Thyrotropin/pharmacology
2.
Medicina [B.Aires] ; 52(3): 207-12, mayo-jun. 1992. graf
Article in English | BINACIS | ID: bin-24813

ABSTRACT

We studied 26 patients with Graves disease, from a population with sufficient iodine supply, treated with high doses of methyl mercaptoimidazole (MMI) during eight moths. We evaluated: a) their evolution after treatment withdrawal; b) the correlation between evolution and TSH-receptor antibodies (TRAb), thyroid hormone levels, microsomal antibodies (MAb), T3/T4 index and clinical data; c) their prognosis. The patients were followed during 12-60 months, and blood samples were collected before treatment withdrawal. Out of 26 patients, 20 relapsed, with T3/T4 index and TRAb significantly higher than those under remission. The T3/T4 index correlated with TRAb. All the TRAb-positive patients, and only 57.1% of the negatives, relapsed. The relapses were significantly more frequent prior to the 6th month in the TRAb-positive patients than afterwards. The TRAb-negatives who relapsed during that period, showed TRAb and age means significantly higher than those under remission. The TRAb test, as a prognostic marker of evolution, showed a sensitivity of 60% and a specificity of 100%. No significant differences were found between evolution to relapse or to remission and the other parameters. It can be concluded that TRAb and T3/T4 index were different in the group that relapsed from that which remitted, and that a TRAb positive value, at the moment of treatment withdrawal, is a useful marker of relapse (Au)


Subject(s)
Humans , Male , Female , Autoimmune Diseases/drug therapy , Graves Disease/drug therapy , Methimazole/therapeutic use , Adult , Autoantibodies/blood , Autoimmune Diseases/blood , Autoimmune Diseases/immunology , Biomarkers/blood , Graves Disease/blood , Graves Disease/immunology , Microsomes/immunology , Middle Aged , Prognosis , Receptors, Thyrotropin/immunology , Recurrence , Remission Induction , Thyroid Hormones/blood
3.
Medicina (B.Aires) ; 52(3): 207-12, mayo-jun. 1992. graf
Article in English | LILACS | ID: lil-134615

ABSTRACT

We studied 26 patients with Graves' disease, from a population with sufficient iodine supply, treated with high doses of methyl mercaptoimidazole (MMI) during eight moths. We evaluated: a) their evolution after treatment withdrawal; b) the correlation between evolution and TSH-receptor antibodies (TRAb), thyroid hormone levels, microsomal antibodies (MAb), T3/T4 index and clinical data; c) their prognosis. The patients were followed during 12-60 months, and blood samples were collected before treatment withdrawal. Out of 26 patients, 20 relapsed, with T3/T4 index and TRAb significantly higher than those under remission. The T3/T4 index correlated with TRAb. All the TRAb-positive patients, and only 57.1% of the negatives, relapsed. The relapses were significantly more frequent prior to the 6th month in the TRAb-positive patients than afterwards. The TRAb-negatives who relapsed during that period, showed TRAb and age means significantly higher than those under remission. The TRAb test, as a prognostic marker of evolution, showed a sensitivity of 60% and a specificity of 100%. No significant differences were found between evolution to relapse or to remission and the other parameters. It can be concluded that TRAb and T3/T4 index were different in the group that relapsed from that which remitted, and that a TRAb positive value, at the moment of treatment withdrawal, is a useful marker of relapse


Subject(s)
Humans , Male , Female , Autoimmune Diseases/drug therapy , Graves Disease/drug therapy , Methimazole/therapeutic use , Adult , Autoantibodies/blood , Autoimmune Diseases/blood , Autoimmune Diseases/immunology , Biomarkers/blood , Graves Disease/blood , Graves Disease/immunology , Middle Aged , Microsomes/immunology , Prognosis , Recurrence , Remission Induction , Receptors, Thyrotropin/immunology , Thyroid Hormones/blood
4.
Medicina (B Aires) ; 52(3): 207-12, 1992.
Article in English | MEDLINE | ID: mdl-1364158

ABSTRACT

We studied 26 patients with Graves' disease, from a population with sufficient iodine supply, treated with high doses of methyl mercaptoimidazole (MMI) during eight moths. We evaluated: a) their evolution after treatment withdrawal; b) the correlation between evolution and TSH-receptor antibodies (TRAb), thyroid hormone levels, microsomal antibodies (MAb), T3/T4 index and clinical data; c) their prognosis. The patients were followed during 12-60 months, and blood samples were collected before treatment withdrawal. Out of 26 patients, 20 relapsed, with T3/T4 index and TRAb significantly higher than those under remission. The T3/T4 index correlated with TRAb. All the TRAb-positive patients, and only 57.1% of the negatives, relapsed. The relapses were significantly more frequent prior to the 6th month in the TRAb-positive patients than afterwards. The TRAb-negatives who relapsed during that period, showed TRAb and age means significantly higher than those under remission. The TRAb test, as a prognostic marker of evolution, showed a sensitivity of 60% and a specificity of 100%. No significant differences were found between evolution to relapse or to remission and the other parameters. It can be concluded that TRAb and T3/T4 index were different in the group that relapsed from that which remitted, and that a TRAb positive value, at the moment of treatment withdrawal, is a useful marker of relapse.


Subject(s)
Autoimmune Diseases/drug therapy , Graves Disease/drug therapy , Methimazole/therapeutic use , Adult , Autoantibodies/blood , Autoimmune Diseases/blood , Autoimmune Diseases/immunology , Biomarkers/blood , Female , Graves Disease/blood , Graves Disease/immunology , Humans , Immunoglobulins, Thyroid-Stimulating , Male , Microsomes/immunology , Middle Aged , Prognosis , Receptors, Thyrotropin/immunology , Recurrence , Remission Induction , Thyroid Hormones/blood , Treatment Outcome
5.
Medicina [B Aires] ; 52(3): 207-12, 1992.
Article in English | BINACIS | ID: bin-37911

ABSTRACT

We studied 26 patients with Graves disease, from a population with sufficient iodine supply, treated with high doses of methyl mercaptoimidazole (MMI) during eight moths. We evaluated: a) their evolution after treatment withdrawal; b) the correlation between evolution and TSH-receptor antibodies (TRAb), thyroid hormone levels, microsomal antibodies (MAb), T3/T4 index and clinical data; c) their prognosis. The patients were followed during 12-60 months, and blood samples were collected before treatment withdrawal. Out of 26 patients, 20 relapsed, with T3/T4 index and TRAb significantly higher than those under remission. The T3/T4 index correlated with TRAb. All the TRAb-positive patients, and only 57.1


of the negatives, relapsed. The relapses were significantly more frequent prior to the 6th month in the TRAb-positive patients than afterwards. The TRAb-negatives who relapsed during that period, showed TRAb and age means significantly higher than those under remission. The TRAb test, as a prognostic marker of evolution, showed a sensitivity of 60


and a specificity of 100


. No significant differences were found between evolution to relapse or to remission and the other parameters. It can be concluded that TRAb and T3/T4 index were different in the group that relapsed from that which remitted, and that a TRAb positive value, at the moment of treatment withdrawal, is a useful marker of relapse.

6.
Medicina [B Aires] ; 52(3): 207-12, 1992.
Article in English | BINACIS | ID: bin-51008

ABSTRACT

We studied 26 patients with Graves disease, from a population with sufficient iodine supply, treated with high doses of methyl mercaptoimidazole (MMI) during eight moths. We evaluated: a) their evolution after treatment withdrawal; b) the correlation between evolution and TSH-receptor antibodies (TRAb), thyroid hormone levels, microsomal antibodies (MAb), T3/T4 index and clinical data; c) their prognosis. The patients were followed during 12-60 months, and blood samples were collected before treatment withdrawal. Out of 26 patients, 20 relapsed, with T3/T4 index and TRAb significantly higher than those under remission. The T3/T4 index correlated with TRAb. All the TRAb-positive patients, and only 57.1


of the negatives, relapsed. The relapses were significantly more frequent prior to the 6th month in the TRAb-positive patients than afterwards. The TRAb-negatives who relapsed during that period, showed TRAb and age means significantly higher than those under remission. The TRAb test, as a prognostic marker of evolution, showed a sensitivity of 60


and a specificity of 100


. No significant differences were found between evolution to relapse or to remission and the other parameters. It can be concluded that TRAb and T3/T4 index were different in the group that relapsed from that which remitted, and that a TRAb positive value, at the moment of treatment withdrawal, is a useful marker of relapse.

7.
Medicina [B.Aires] ; 47(5): 464-70, sept.-oct. 1987. ilus
Article in Spanish | BINACIS | ID: bin-30187

ABSTRACT

En este trabajo, tomando un método descripto por Ridgway y col. se analizaron pruebas de TRH-TSH con el objeto de: a) expresar este examen funcional mediante un valor numérico; b) establecer sus valores en sujetos normales; c) comparar la capacidad discriminativa de esta prueba en relación con otros parámetros de función y diagnóstico clínico, y d) estudiar la validez de una prueba corta estableciendo los tiempos más adecuados para la misma. El área bajo la curva de TRS-TSH discriminó perfectamente al grupo testigo (877 ñ 57 micronUI/ml1/min) de los tirotóxicos (145 ñ 25) y de los hipotiroideos (8846 ñ 1092). El análisis de las tiroideopatías eutiroideas mostró la presencia de dos grupos que se ubicaron funcionalmente uno entre los tirotóxicos y los testigos (266 ñ 17 micronUI/ml1/min) y otro entre los hipotiroideos y los testigos (2610 ñ 195). Estos eran dos grupos estadísticamente diferentes a los clásicamente conocidos, que no se podían diferenciar por los niveles séricos de T3 y T4, ya que estaban dentro de parámetros normales y a los que definimos como hipertiroideos subclínicos e hipotiroideos subclínicos, respectivamente. El análisis global de todas las curvas estudiadas mostró que de los cuatro parámetros de función analizados, T4, T3, TSH basal y área de TRH-TSH, el que mostró mayor poder discriminativo fue el último, pudiéndose establecer nueve estadios funcionales diferentes que abarcan toda una gama que va desde la tirotoxicosis franca hasta el hipotiroidismo manifiesto. Se buscó la correlación entre el área total y una área corta de 20 y 30min, siendo la misma altamente significaticva (r + 0,975; p <0,000001). El delta de TSH se produjo en el 77% de los casos entre los 20 y 30min en el 12,8% a los 40min. Se puede concluir que el cálculo del área bajo la curva de TRH-TSH es el método más válido para valorar función tiroidea (AU)


Subject(s)
Adolescent , Adult , Humans , Male , Female , Comparative Study , Thyroid Gland/physiology , Thyrotropin-Releasing Hormone/blood , Thyroid Function Tests/methods , Thyrotropin/diagnosis
8.
Medicina (B.Aires) ; 47(5): 464-70, sept.-oct. 1987. ilus
Article in Spanish | LILACS | ID: lil-59155

ABSTRACT

En este trabajo, tomando un método descripto por Ridgway y col. se analizaron pruebas de TRH-TSH con el objeto de: a) expresar este examen funcional mediante un valor numérico; b) establecer sus valores en sujetos normales; c) comparar la capacidad discriminativa de esta prueba en relación con otros parámetros de función y diagnóstico clínico, y d) estudiar la validez de una prueba corta estableciendo los tiempos más adecuados para la misma. El área bajo la curva de TRS-TSH discriminó perfectamente al grupo testigo (877 ñ 57 micronUI/ml1/min) de los tirotóxicos (145 ñ 25) y de los hipotiroideos (8846 ñ 1092). El análisis de las tiroideopatías eutiroideas mostró la presencia de dos grupos que se ubicaron funcionalmente uno entre los tirotóxicos y los testigos (266 ñ 17 micronUI/ml1/min) y otro entre los hipotiroideos y los testigos (2610 ñ 195). Estos eran dos grupos estadísticamente diferentes a los clásicamente conocidos, que no se podían diferenciar por los niveles séricos de T3 y T4, ya que estaban dentro de parámetros normales y a los que definimos como hipertiroideos subclínicos e hipotiroideos subclínicos, respectivamente. El análisis global de todas las curvas estudiadas mostró que de los cuatro parámetros de función analizados, T4, T3, TSH basal y área de TRH-TSH, el que mostró mayor poder discriminativo fue el último, pudiéndose establecer nueve estadios funcionales diferentes que abarcan toda una gama que va desde la tirotoxicosis franca hasta el hipotiroidismo manifiesto. Se buscó la correlación entre el área total y una área corta de 20 y 30min, siendo la misma altamente significaticva (r + 0,975; p <0,000001). El delta de TSH se produjo en el 77% de los casos entre los 20 y 30min en el 12,8% a los 40min. Se puede concluir que el cálculo del área bajo la curva de TRH-TSH es el método más válido para valorar función tiroidea


Subject(s)
Adolescent , Adult , Humans , Male , Female , Thyroid Gland/physiology , Thyrotropin-Releasing Hormone/blood , Thyroid Function Tests/methods , Thyrotropin
11.
Neuroendocrinology ; 43(4): 498-503, 1986.
Article in English | MEDLINE | ID: mdl-3748308

ABSTRACT

To assess the role of peripheral sympathetic nerves in the regulation of calcitonin release, rats subjected to superior cervical ganglionectomy (SCGx) 16-28 h earlier were used. The time periods selected allowed us to examine C cell response during the supraliminal release of sympathetic transmitter that accompanies anterograde degeneration of nerve varicosities as well as during the neural paralysis that ensues thereafter. At the time intervals examined, SCGx did not result in significant changes of basal serum calcitonin or Ca levels. The intraperitoneal administration of CaCl2 brought about an impending increase of serum Ca to the same extent in SCGx and sham-operated rats. A significant depression of calcitonin release was observed in rats killed around the time of nerve terminal degeneration (16-21 h post SCGx) but not about 10 h later. Additionally a delay to achieve a maximal calcitonin response was apparent during nerve degeneration. Injection of the alpha-adrenoceptor blocker phenoxybenzamine significantly increased basal calcitonin levels and restored the depressed calcitonin response to hypercalcemia seen in SCGx rats. Treatment with the beta-adrenoceptor-blocker propranolol counteracted phenoxybenzamine activity but was unable to modify per se calcitonin release in SCGx or sham-operated rats. Basal Ca levels and their increase after intraperitoneal CaCl2 were similar in all examined groups regardless of the drug injected. In an additional experiment phenoxybenzamine injected into SCGx rats in doses one-fifth those employed earlier still reversed both the depression in maximal calcitonin response as well as the delay to attain maximal release after CaCl2, but was unable to affect basal calcitonin levels.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Calcitonin/blood , Ganglia, Sympathetic/surgery , Nerve Degeneration , Animals , Calcium/blood , Calcium Chloride/pharmacology , Male , Norepinephrine/metabolism , Phenoxybenzamine/pharmacology , Rats , Rats, Inbred Strains , Thyroid Gland/innervation , Thyroid Gland/metabolism , Time Factors
12.
Surgery ; 81(4): 392-8, 1977 Apr.
Article in English | MEDLINE | ID: mdl-15327

ABSTRACT

Acid instillation into the duodenum inhibits basal and stimulated gastric secretion. In man vagotomy suppresses this secretory inhibition. It is postulated that such inhibition responds to a dual mechanism: an hormonal one (enterogastrone) and a nervous one (vagus nerve). This study showed that preoperative duodenal acidification of duodenal ulcer patients results in a decrease in basal gastric secretion and in gastrin levels. On the contrary, in patients submitted to vagal denervation--either through truncal division or highly selective vagotomy--duodenal acidification does not inhibit gastric secretion; however, a drop occurs in basal gastrin levels. An intact gastric vagal innervation therefore, seems necessary for the preservation of the sensitivity of the parietal cell to the effect of hormonal inhibitors, it being immaterial whether duodenal innervation is present or not, as that duodenal acidification provokes a significant fall in serum gastrin levels as determined by radioimmunoassay. This hormonal decrease produced by duodenal acidification can be explained by the inhibition of gastrin release from the antrum. Agreement is expressed with the opinion of other authors that highly selective vagotomy does not appear to carry any advantage over truncal section of the vagus nerves from the standpoint of the inhibitory mechanism of gastric secretion from the duodenum.


Subject(s)
Duodenum/metabolism , Gastric Juice/metabolism , Gastrins/metabolism , Gastrins/blood , Humans , Hydrochloric Acid/administration & dosage , Hydrogen-Ion Concentration , Middle Aged , Vagotomy
SELECTION OF CITATIONS
SEARCH DETAIL
...